In PAH, TNF-α, IL-6, and IL-1β lead to pulmonary arterial remodeling as they can cause damage in pulmonary endothelial cells, promoting abnormal PASMCs migration and proliferation [40,41]. The gene discussed is IL6; the disease is pulmonary arterial hypertension.